Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
Completed
- Conditions
- Covid19
- Registration Number
- NCT04496141
- Lead Sponsor
- Hong Kong Sanatorium & Hospital
- Brief Summary
Achieved serum samples of persons with or without evidence of COVID-19 infection are tested using the different commercial SARS-CoV-2 antibody immunoassays. The performance of the immunoassays is then assessed by comparing the 2 groups of samples.
- Detailed Description
Achieved serum samples of the different testing groups are retrieved and tested with the immunoassays according to manufacturer's instruction.
The test results are then compared and analyzed with statistical tests to assess the immunoassays'performance
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The accuracy of the different commercial SARS-CoV-2 antibody immunoassays 1 month To investigate the accuracy (including sensitivity, specificity, positive and negative predictive value) of the commercial SARS-CoV-2 antibody immunoassays
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hong Kong Sanatorium & Hospital
🇭🇰Hong Kong, Hong Kong
Hong Kong Sanatorium & Hospital🇭🇰Hong Kong, Hong Kong